Education
About Us
Working with TipRanks
Follow Us
Cooper Co (COO)
NASDAQ:COO
COO Stock Chart & Stats
$78.51
-$0.81(-0.88%)
At close: 4:00 PM EST
$78.51
-$0.81(-0.88%)
Day’s Range― - ―
52-Week Range$61.78 - $100.47
Previous CloseN/A
Volume244.93K
Average Volume (3M)2.84M
Market Cap
$16.18B
Enterprise Value$16.52B
Total Cash (Recent Filing)$124.90M
Total Debt (Recent Filing)$2.48B
Price to Earnings (P/E)41.6
Beta0.77
Next Earnings
Feb 26, 2026EPS Estimate
1.03Last Dividend Ex-Date
Jul 26, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)1.15
Shares Outstanding195,978,030
10 Day Avg. Volume4,003,876
30 Day Avg. Volume2,842,411
Financial Highlights & Ratios
PEG Ratio-7.35
Price to Book (P/B)0.00
Price to Sales (P/S)3.42
P/FCF Ratio0.00
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue4.08
Enterprise Value/Gross Profit6.10
Enterprise Value/Ebitda15.15
Forecast
1Y Price Target
$89.67Price Target Upside14.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)4.51
Revenue Forecast (FY)$4.32B
Bulls Say, Bears Say
Bulls Say
Operational EfficiencyCOO expects pretax savings of $50 million in FY26 from acquisition-related integration work, indicating potential for improved operational efficiency.
Shareholder ValueThe strategic review suggests all options are on the table, including the potential separation of CVI and CSI, aimed at maximizing shareholder value.
Strategic ReviewThe company announced a succession of the Chairman role at the Board level and the launch of a comprehensive strategic review, indicating a proactive approach to future business strategy.
Bears Say
Regulatory ChallengesSignificant regulatory hurdles are expected for the acquisition of Bausch & Lomb’s Contact Lens business, raising concerns over industry concentration.
Return On InvestmentCooper’s recent acquisitions in Women’s Health have not helped the company’s ROIC and have not generated adequate returns.
Revenue GuidanceNew revenue guidance was a little below Street expectations.
Cooper Co News
COO FAQ
What was Cooper Co’s price range in the past 12 months?
Cooper Co lowest stock price was $61.77 and its highest was $100.47 in the past 12 months.
What is Cooper Co’s market cap?
Cooper Co’s market cap is $16.18B.
When is Cooper Co’s upcoming earnings report date?
Cooper Co’s upcoming earnings report date is Feb 26, 2026 which is in 78 days.
How were Cooper Co’s earnings last quarter?
Cooper Co released its earnings results on Dec 04, 2025. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.113 by $0.037.
Is Cooper Co overvalued?
According to Wall Street analysts Cooper Co’s price is currently Undervalued.
Does Cooper Co pay dividends?
Cooper Co pays a Semiannually dividend of $0.007 which represents an annual dividend yield of N/A. See more information on Cooper Co dividends here
What is Cooper Co’s EPS estimate?
Cooper Co’s EPS estimate is 1.03.
How many shares outstanding does Cooper Co have?
Cooper Co has 195,978,030 shares outstanding.
What happened to Cooper Co’s price movement after its last earnings report?
Cooper Co reported an EPS of $1.15 in its last earnings report, beating expectations of $1.113. Following the earnings report the stock price went up 5.673%.
Which hedge fund is a major shareholder of Cooper Co?
Currently, no hedge funds are holding shares in COO
Cooper Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.67 (14.21% Upside)
$89.67 (14.21% Upside)
Blogger Sentiment
Bullish
COO Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 240.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $136.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 4.6%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.93%
12-Months-Change
Fundamentals
Return on Equity
4.59%
Trailing 12-Months
Asset Growth
0.65%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cooper Co
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO Company Deck
COO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The company's earnings call reflected a focus on strong financial performance and strategic growth initiatives. While CooperVision and the share repurchase program showed significant positive trends, challenges in certain markets, particularly in China and the fertility segment, posed some concerns.View all COO earnings summariesCOO Net sales Breakdown
67.05% CooperVision
32.95% CooperSurgical
COO Stock 12 Month Forecast
Average Price Target
$89.67
▲(14.21% Upside)
Technical Analysis
Ownership Overview
0.24% Insiders
35.98% Mutual Funds
33.94% Other Institutional Investors
4.85% Public Companies and
Individual Investors